Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPRISE: Parimifasor in moderate chronic plaque-type psoriasis
NCT02872285Phase 2Completed
- Sponsor
- Lycera
- Start
- Dec 2016
- Primary completion
- Jun 2017
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of parimifasor in plaque psoriasis, sponsored by Lycera. Started Dec 2016; status: completed.
02
Drugs
parimifasor
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02872285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872285.